These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 19229702

  • 1. TORCH and UPLIFT: what has been learned from the COPD "mega-trials"?
    Niewoehner DE.
    COPD; 2009 Feb; 6(1):1-3. PubMed ID: 19229702
    [Abstract] [Full Text] [Related]

  • 2. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP.
    Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [Abstract] [Full Text] [Related]

  • 3. Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone.
    Kurashima K, Hara K, Yoneda K, Kanauchi T, Kagiyama N, Tokunaga D, Takayanagi N, Ubukata M, Sugita Y.
    Respirology; 2009 Mar; 14(2):239-44. PubMed ID: 19210650
    [Abstract] [Full Text] [Related]

  • 4. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.
    Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M, Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium.
    Ann Intern Med; 2007 Apr 17; 146(8):545-55. PubMed ID: 17310045
    [Abstract] [Full Text] [Related]

  • 5. Comparison of tiotropium plus fluticasone propionate/salmeterol with tiotropium in COPD: a randomized controlled study.
    Jung KS, Park HY, Park SY, Kim SK, Kim YK, Shim JJ, Moon HS, Lee KH, Yoo JH, Lee SD, Korean Academy of Tuberculosis and Respiratory Diseases study group, Korea Chronic Obstructive Pulmonary Disease study group.
    Respir Med; 2012 Mar 17; 106(3):382-9. PubMed ID: 21975275
    [Abstract] [Full Text] [Related]

  • 6. [Combination of inhaled salmeterol/fluticasone and tiotropium in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial].
    Fang LZ, Liang X, Zhang JQ, Liu L, Fu WP, Zhao ZH, Dai LM.
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov 17; 31(11):811-4. PubMed ID: 19080533
    [Abstract] [Full Text] [Related]

  • 7. [Impact of efficacy and mortality studies (TORCH and UPLIFT) in bronchodilator treatment of chronic obstructive pulmonary disease].
    Soler-Cataluña JJ, García MA.
    Arch Bronconeumol; 2009 Nov 17; 45 Suppl 5():14-20. PubMed ID: 20116757
    [Abstract] [Full Text] [Related]

  • 8. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
    Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J, TORCH investigators.
    N Engl J Med; 2007 Feb 22; 356(8):775-89. PubMed ID: 17314337
    [Abstract] [Full Text] [Related]

  • 9. Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD.
    Hanania NA, Crater GD, Morris AN, Emmett AH, O'Dell DM, Niewoehner DE.
    Respir Med; 2012 Jan 22; 106(1):91-101. PubMed ID: 22040533
    [Abstract] [Full Text] [Related]

  • 10. Effects of adding salmeterol/fluticasone propionate to tiotropium on airway dimensions in patients with chronic obstructive pulmonary disease.
    Hoshino M, Ohtawa J.
    Respirology; 2011 Jan 22; 16(1):95-101. PubMed ID: 20920142
    [Abstract] [Full Text] [Related]

  • 11. Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial.
    Tashkin DP.
    Expert Rev Respir Med; 2010 Jun 22; 4(3):279-89. PubMed ID: 20524910
    [Abstract] [Full Text] [Related]

  • 12. Investigating new standards for prophylaxis in reduction of exacerbations--the INSPIRE study methodology.
    Seemungal T, Stockley R, Calverley P, Hagan G, Wedzicha JA.
    COPD; 2007 Sep 22; 4(3):177-83. PubMed ID: 17729060
    [Abstract] [Full Text] [Related]

  • 13. Chronic obstructive pulmonary disease megatrials: taking the results into office practice.
    Stoloff SW.
    Am J Med Sci; 2011 Aug 22; 342(2):160-7. PubMed ID: 21512392
    [Abstract] [Full Text] [Related]

  • 14. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL, Baker EL, Coleman CI.
    Pharmacotherapy; 2009 Aug 22; 29(8):891-905. PubMed ID: 19637942
    [Abstract] [Full Text] [Related]

  • 15. Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT studies.
    Miravitlles M, Anzueto A.
    Int J Chron Obstruct Pulmon Dis; 2009 Aug 22; 4():185-201. PubMed ID: 19516917
    [Abstract] [Full Text] [Related]

  • 16. [Inhaled corticosteroids in patients with COPD: maintain current guidelines].
    Heijdra YF.
    Ned Tijdschr Geneeskd; 2007 Oct 06; 151(40):2195-7. PubMed ID: 17969568
    [Abstract] [Full Text] [Related]

  • 17. Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations.
    Ferguson GT, Anzueto A, Fei R, Emmett A, Knobil K, Kalberg C.
    Respir Med; 2008 Aug 06; 102(8):1099-108. PubMed ID: 18614347
    [Abstract] [Full Text] [Related]

  • 18. Is salmeterol/fluticasone propionate equivalent to tiotropium bromide in the treatment of COPD?
    Gillissen A.
    Am J Respir Crit Care Med; 2008 Jul 01; 178(1):105; author reply 106-7. PubMed ID: 18565963
    [No Abstract] [Full Text] [Related]

  • 19. Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD.
    Schermer TR, Albers JM, Verblackt HW, Costongs RJ, Westers P.
    Fam Pract; 2007 Apr 01; 24(2):181-8. PubMed ID: 17251178
    [Abstract] [Full Text] [Related]

  • 20. Tiotropium and salmeterol/fluticasone combination do not cause oxygen desaturation in COPD.
    Andò F, Ruggeri P, Girbino G, Cazzola M.
    Respir Med; 2008 Jun 01; 102(6):815-8. PubMed ID: 18343646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.